* Ultralife Corp ULBI.OQ ULBI.O is expected to show a
rise in
quarterly revenue when it reports results on April 25 for the
period ending March 31 2024
* The Newark New York New York-based company is expected to
report a 19.1% increase in revenue to $38 million from $31.92
million a year ago, according to the estimate from one analyst,
based on LSEG data.
* LSEG's mean analyst estimate for Ultralife Corp is for
earnings
of 10 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the electrical
components & equipment peer group is also "Buy".
* Wall Street's median 12-month price target for Ultralife
Corp is
$12.00, above its last closing price of $8.69.
This summary was machine generated April 23 at 12:59 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)